United States Antimony (UAMY) 10-Q 15 Nov 21 2021 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2021	Nov. 15, 2021
Cover [Abstract]
Entity Registrant Name	UNITED STATES ANTIMONY CORPORATION
Entity Central Index Key	0000101538
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Sep. 30, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		106,117,844
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-08675
Entity Incorporation State Country Code	MT
Entity Tax Identification Number	81-0305822
Entity Address Address Line 1	P.O. Box 643
Entity Address City Or Town	Thompson Falls
Entity Address State Or Province	MT
Entity Address Postal Zip Code	00000
City Area Code	406
Local Phone Number	827-3523
Security 12b Title	Common Stock, $0.01 par value
Trading Symbol	UAMY
Security Exchange Name	NYSEAMER
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 21,563,500	$ 665,102
Certificates of deposit	44,028	254,212
Accounts receivable	722,727
Inventories (Note 5)	733,956	650,213
Total current assets	23,064,211	1,808,161
Properties, plants and equipment, net (Note 13)	11,176,469	11,225,594
Restricted cash for reclamation bonds	57,275	57,275
IVA receivable and other assets	239,084	208,472
Total assets	34,537,039	13,299,502
Current liabilities:
Checks issued and payable	0	86,685
Accounts payable	1,252,846	1,876,874
Accrued liabilities (Note 6)	571,209	635,626
Payables to related party (Note 9)	171,017	227,432
Notes payable to bank (Note 7)	0	100,000
Export tax assessment payable (Note 11)	0	1,120,730
Hillgrove advances payable (Note 12)	0	378,074
Long-term debt, current portion (Note 8)	0	52,122
Total current liabilities	1,824,055	4,477,543
Long-term debt, net of current portion (Note 8)	0	34,304
Hillgrove advances payable (Note 12)	0	756,147
CARES Act note payable (Note 14)	0	443,400
Stock payable to directors for services (Note 10)	84,375	110,000
Asset retirement obligations and accrued reclamation costs	296,916	291,719
Total liabilities	2,205,346	6,113,113
Stockholders' equity:
Common stock, $0.01 par value, 150,000,000 shares authorized; 106,117,844 and 75,949,757 shares issued and outstanding, respectively	1,061,177	759,496
Additional paid-in capital	63,992,101	39,050,899
Accumulated deficit	(32,748,373)	(32,650,794)
Total stockholders' equity	32,331,693	7,186,389
Total liabilities and stockholders' equity	34,537,039	13,299,502
Series A
Stockholders' equity:
Series A: -0- shares issued and outstanding	0	0
Series B
Stockholders' equity:
Series A: -0- shares issued and outstanding	7,500	7,500
Series C
Stockholders' equity:
Series A: -0- shares issued and outstanding	1,779	1,779
Series D
Stockholders' equity:
Series A: -0- shares issued and outstanding	$ 17,509	$ 17,509

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized shares	150,000,000	150,000,000
Common stock, issued shares	106,117,844	75,949,757
Common stock, outstanding shares	106,117,844	75,949,757
Series A
Preferred stock, par value	$ 0.01	$ 10,000,000
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Series B
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	750,000	750,000
Preferred stock, outstanding shares	750,000	750,000
Preferred stock liquidation preference	$ 945,000	$ 937,500
Series C
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	177,904	177,904
Preferred stock, outstanding shares	177,904	177,904
Preferred stock liquidation preference	$ 97,847	$ 97,847
Series D
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	1,751,005	1,751,005
Preferred stock, outstanding shares	1,751,005	1,751,005
Preferred stock liquidation preference	$ 5,084,770	$ 5,043,622

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - Unaudited - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Condensed Consolidated Statements of Operations - Unaudited
REVENUES	$ 2,051,713	$ 1,007,231	$ 5,580,562	$ 4,335,413
COST OF REVENUES	1,950,504	1,442,322	5,070,798	4,685,388
GROSS PROFIT (LOSS)	101,209	(435,091)	509,764	(349,975)
OPERATING EXPENSES:
General and administrative	112,744	110,051	572,905	429,973
Salaries and benefits	72,200	82,308	226,137	288,455
Site care and maintenance expenses	0	0	184,037	24,250
Professional fees	28,227	43,557	212,563	161,167
Loss on abandonment of mineral properties	0	318,502	0	(318,502)
TOTAL OPERATING EXPENSES	213,171	554,418	1,195,642	1,222,347
LOSS FROM OPERATIONS	(111,962)	(989,509)	(685,878)	(1,572,322)
OTHER INCOME (EXPENSE):
Interest income	13,320	19	35,202	854
Interest expense	(590)	(3,750)	(3,725)	(14,937)
Gain on forgiveness of CARES Act debt (Note 14)	0	0	443,400	0
Grant income	0	0	0	10,000
Gain on settlement of Hillgrove advance (Note 12)	0	0	113,422	0
TOTAL OTHER INCOME (EXPENSE)	12,730	(3,731)	588,299	(4,083)
NET LOSS	(99,232)	(993,240)	(97,579)	(1,576,405)
Preferred dividends	(12,162)	(12,162)	(36,487)	(36,487)
Net loss available to common stockholders	$ (111,394)	$ (1,005,402)	$ (134,066)	$ (1,612,892)
Net loss per share of common stock:
Basic and diluted	$ 0	$ (0.01)	$ 0	$ (0.02)
Weighted average shares outstanding:
Basic and diluted	106,117,844	73,240,218	101,642,048	71,033,733

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2019		2,678,909	69,661,436
Balance, amount at Dec. 31, 2019	$ 8,467,142	$ 26,788	$ 696,614	$ 37,107,730	$ (29,363,990)
Issuance of common stock upon exercise of warrants, shares			250,000
Issuance of common stock upon exercise of warrants, amount	62,500	0	$ 2,500	60,000	0
Issuance of common stock to Directors, shares			295,463
Issuance of common stock to Directors, amount	130,483	0	$ 2,954	127,529	0
Issuance of common stock and warrants for cash, shares			5,742,858
Issuance of common stock and warrants for cash, amount	2,010,000	0	$ 57,428	1,952,572	0
Common stock issuance costs	(196,932)	0	0	(196,932)	0
Net loss	(1,576,405)	$ 0	$ 0	0	(1,576,405)
Balance, shares at Sep. 30, 2020		2,678,909	75,949,757
Balance, amount at Sep. 30, 2020	8,896,788	$ 26,788	$ 759,496	39,050,899	(30,940,395)
Balance, shares at Jun. 30, 2020		2,678,909	70,206,899
Balance, amount at Jun. 30, 2020	8,076,960	$ 26,788	$ 702,068	37,295,259	(29,947,155)
Issuance of common stock and warrants for cash, shares			5,742,858
Issuance of common stock and warrants for cash, amount	2,010,000	0	$ 57,428	1,952,572	0
Common stock issuance costs	(196,932)	0	0	(196,932)	0
Net loss	(993,240)	$ 0	$ 0	0	(993,240)
Balance, shares at Sep. 30, 2020		2,678,909	75,949,757
Balance, amount at Sep. 30, 2020	8,896,788	$ 26,788	$ 759,496	39,050,899	(30,940,395)
Balance, shares at Dec. 31, 2020		2,678,909	75,949,757
Balance, amount at Dec. 31, 2020	7,186,389	$ 26,788	$ 759,496	39,050,899	(32,650,794)
Issuance of common stock to Directors, shares			112,610
Issuance of common stock to Directors, amount	110,000	0	$ 1,126	108,874	0
Net loss	(97,579)	0	$ 0	0	(97,579)
Issuance of common stock for cash (Note 10), shares			26,290,000
Issuance of common stock for cash (Note 10), amount	24,997,000		$ 262,900	24,734,100	0
Common stock issuance costs (Note 10)	(1,654,820)	0	$ 0	(1,654,820)	0
Common stock issued upon exercise of warrants (Note 10), shares			3,765,477
Common stock issued upon exercise of warrants (Note 10), amount	1,790,703	$ 0	$ 37,655	1,753,048	0
Balance, shares at Sep. 30, 2021		2,678,909	106,117,844
Balance, amount at Sep. 30, 2021	32,331,693	$ 26,788	$ 1,061,177	63,992,101	(32,748,373)
Balance, shares at Jun. 30, 2021		2,678,909	106,005,234
Balance, amount at Jun. 30, 2021	32,320,925	$ 26,788	$ 1,060,051	63,883,227	(32,649,141)
Issuance of common stock to Directors, shares			112,610
Issuance of common stock to Directors, amount	110,000	0	$ 1,126	108,874	0
Net loss	(99,232)	$ 0	$ 0	0	(99,232)
Balance, shares at Sep. 30, 2021		2,678,909	106,117,844
Balance, amount at Sep. 30, 2021	$ 32,331,693	$ 26,788	$ 1,061,177	$ 63,992,101	$ (32,748,373)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows From Operating Activities:
Net loss	$ (97,579)	$ (1,576,405)
Adjustments to reconcile net loss to net cash provided (used) by operating activities:
Depreciation and amortization	665,604	667,298
Loss on abandonment of mineral properties	0	318,502
Accretion of asset retirement obligation	5,197	6,118
Common stock payable for directors fees	84,375	89,858
Gain on settlement of Hillgrove advance	(113,422)	0
Gain on forgiveness of Cares Act debt	(443,400)	0
Other non-cash items	0	(661)
Change in:
Accounts receivable	(484,093)	62,399
Inventories	(83,743)	61,194
IVA receivable and other assets	(30,612)	10,119
Accounts payable	(624,028)	(252,183)
Accrued liabilities	(64,417)	25,769
Export tax assessment payable	(1,120,730)	0
Payables to related parties	(171,016)	21,405
Net cash used by operating activities	(2,477,864)	(566,587)
Cash Flows From Investing Activities:
Proceeds from redemption of certificates of deposit	210,184	0
Purchase of properties, plants and equipment	(616,479)	(220,455)
Net cash used by investing activities	(406,295)	(220,455)
Cash Flows From Financing Activities:
Change in checks issued and payable	(86,685)	(2,879)
Net proceeds from (payments to) factor	0	(5,032)
Payments on advances from related party	(56,416)	(64,650)
Proceeds from note payable-SBA	0	443,400
Proceeds from issuance of common stock, net of issuance costs	23,342,180	1,813,068
Proceeds from exercise of warrants	1,790,703	0
Payments on Hillgrove advances payable	(1,020,799)	0
Borrowing on notes payable to bank	0	(46,270)
Principal paid on notes payable to bank	(100,000)	0
Principal payments of long-term debt	(86,426)	(30,876)
Net cash provided by financing activities	23,782,557	2,106,761
NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	20,898,398	1,319,719
Cash and cash equivalents and restricted cash at beginning of period	665,102	172,767
Cash and cash equivalents and restricted cash at end of period	21,563,500	1,492,486
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock payable issued to directors (Note 10)	110,000	130,483
Payable to related party satisfied with issuance of stock (Note 10)	$ 0	$ 62,500

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2021
Basis of Presentation
1. Basis of Presentation	1. Basis of Presentation The unaudited consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America for interim financial information, as well as the instructions to Form 10‑Q. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of the Company’s management, all adjustments (consisting of only normal recurring accruals) considered necessary for a fair presentation of the interim financial statements have been included. Operating results for the three and nine month periods ended September 30, 2021 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2021. For further information refer to the financial statements and footnotes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Going Concern Consideration At September 30, 2021, the Company’s condensed consolidated financial statements show working capital of approximately $21.2 million and an accumulated deficit of approximately $32.7 million. The Company has incurred losses for the past two fiscal years which are principally a result of the Company’s antimony operations due to both depressed antimony prices and production costs incurred in Mexico. To improve conditions, the Company continues searching for areas to reduce these production costs. In the nine months of 2021, the Company raised net proceeds of approximately $23.3 million from sale of shares of its common stock and approximately $1.8 million from the exercise of stock purchase warrants. These funds have been and will continue to be used for general corporate purposes, working capital, hiring of additional labor, leverage for reducing legacy contracts, additional managerial staff at United States Antimony Corporation (“USAC”) and Bear River Zeolite (“BRZ”) headquarters, a revised website including measures aimed at increased visibility for advertising, more labor at its Mexican smelter, repair and improved infrastructure at the Mexican smelter, potential securement of additional antimony mine reserves in Mexico, and improvement of furnaces in Montana. With the funds raised, management believes the Company has sufficient funds to sustain its operations and meet its financial obligations during the twelve months following the date of issuance of these condensed consolidated financial statements.

Developments in Accounting Pron

Developments in Accounting Pronouncements	9 Months Ended
	Sep. 30, 2021
Developments in Accounting Pronouncements
2. Developments in Accounting Pronouncements	2. Developments in Accounting Pronouncements Accounting Standards Updates Adopted In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update contains a number of provisions intended to simplify the accounting for income taxes. The update was adopted as of January 1, 2021, and its adoption did not have a material impact on the Company’s condensed consolidated financial statements. Accounting Standards Updates to Become Effective in Future Periods In August 2020, the FASB issued ASU No . - - - Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the condensed consolidated financial statements upon adoption.

Income (Loss) Per Common Share

Income (Loss) Per Common Share	9 Months Ended
	Sep. 30, 2021
Net loss per share of common stock:
3. Income (Loss) Per Common Share	3. Income (Loss) Per Common Share Basic earnings per share is calculated by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible preferred stock. At September 30, 2021 and 2020, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive are as follows: September 30, 2021 September 30, 2020 Warrants 12,489,922 6,194,899 Convertible preferred stock 1,751,005 1,751,005 Total possible dilution 14,240,927 7,945,904

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2021
Revenue Recognition
4. Revenue Recognition	4. Revenue Recognition Products consist of the following: · Antimony: includes antimony oxide, sodium antimonate, antimony trisulfide, and antimony metal · Zeolite: includes coarse and fine zeolite crushed in various sizes · Precious Metals: includes unrefined and refined gold and silver 4. Revenue Recognition, Continued: Sales of products for the three and nine month periods ended September 30, 2021 and 2020 were as follows: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Antimony $ 1,284,969 $ 477,273 $ 3,371,015 $ 2,509,183 Zeolite 693,008 481,126 1,929,383 1,653,201 Precious metals 73,736 48,832 280,164 173,029 $ 2,051,713 $ 1,007,231 $ 5,580,562 $ 4,335,413 The following is sales information by geographic area based on the location of customers for the three and nine month periods ended September 30, 2021 and 2020: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 United States $ 1,805,456 $ 891,090 $ 4,954,412 $ 3,893,374 Canada 246,257 116,141 626,150 442,039 $ 2,051,713 $ 1,007,231 $ 5,580,562 $ 4,335,413 Sales of products to significant customers were as follows for the three and nine month periods ended September 30, 2021 and 2020: For the Three Months Ended For the Nine Months Ended Sales to September 30, September 30, September 30, September 30, Largest Customers 2021 2020 2021 2020 Company A 288,640 114,075 778,211 404,447 Company B 581,609 105,865 1,284,206 - Company C - - 518,226 523,660 Company D 225,800 - 225,800 - Company E - 131,360 - 345,899 $ 1,096,049 $ 351,300 $ 2,806,443 $ 1,274,006 % of Total Revenues 53.42 % 34.88 % 50.29 % 29.39 % At September 30, 2021, the Company had a sales order backlog of 1,192 tons of zeolite and 44,092 pounds of antimony. Accounts receivable from largest customers were as follows at September 30, 2021 and December 31, 2020: Largest Accounts Receivable September 30, 2021 December 31, 2020 Company B $ 222,100 $ - Company F 110,864 - Company G 54,400 68,055 Company H - 21,619 Company I - 16,600 Company J - 12,255 $ 387,364 $ 118,529 % of Total Receivables 53.60 % 49.67 % Our trade accounts receivable balance related to contracts with customers was $722,727 at September 30, 2021 and $238,634 at December 31, 2020. Our products do not involve any warranty agreements and product returns are not typical.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2021
Inventories
5. Inventories	5. Inventories Inventories at September 30, 2021 and December 31, 2020 consisted primarily of finished antimony products, antimony metal, antimony ore, and finished zeolite products that are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products, antimony metal and finished zeolite products costs include raw materials, direct labor and processing facility overhead costs and freight. Inventories at September 30, 2021 and December 31, 2020 are as follows: September 30, 2021 December 31, 2020 Antimony Metal $ 116,325 $ 268,100 Antimony Oxide 214,659 67,377 Antimony Ore 211,788 95,880 Total antimony 542,772 431,357 Zeolite 191,184 218,856 $ 733,956 $ 650,213 Antimony oxide inventory consisted of finished product oxide held at the Company’s plants in Montana and Mexico. Antimony concentrates and ore were held primarily at sites in Mexico and are essentially raw material. The Company’s zeolite inventory consists of salable zeolite material. As of September 30, 2021 and December 31, 2020, all inventory is valued at cost except for antimony ore inventory in Mexico which was valued at net realizable value as of December 31, 2020.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies
6. Commitments and Contingencies	6. Commitments and Contingencies The Company pays various royalties on the sale of zeolite products. On a combined basis, royalties vary from 8%-13%. During the three and nine month periods ended September 30, 2021, the Company had royalty expense of $64,212 and $195,779, respectively. During the three and nine month periods ended September 30, 2020, the Company had royalty expense of $52,569 and $178,187, respectively. At September 30, 2021 and December 31, 2020, the Company had accrued royalties payable of $376,704 and $434,981, respectively, which is included in accrued liablities. The Company is currently in negotiations with certain royalty holders to modify the terms of the agreements.

Notes Payable to Bank

Notes Payable to Bank	9 Months Ended
	Sep. 30, 2021
Notes Payable to Bank
7. Notes Payable to Bank	7. Notes Payable to Bank At September 30, 2021 and December 31, 2020, the Company had the following notes payable to bank: 2021 2020 Promissory note payable to First Security Bank of Missoula, bearing interest at 3.150%, payable on demand, collateralized by a lien on Certificate of Deposit $ - $ 99,999 Promissory note payable to First Security Bank of Missoula, bearing interest at 3.150%, payable on demand, collateralized by a lien on Certificate of Deposit - 1 Total notes payable to the bank $ - $ 100,000 The notes are paid in full as of September 30, 2021 and the lien on the Certificate of Deposit has been released. An amount of $210,184 of the Certificate of Deposit was released during the nine months ended September 30, 2021 and the cash was transferred to the checking account, leaving a Certificate of Deposits balance of $44,028 at September 30, 2021 compared to $254,212 at December 31, 2020.

Debt

Debt	9 Months Ended
	Sep. 30, 2021
Debt
8. Debt	8. Debt Long-Term debt at September 30, 2021 and December 31, 2020 is as follows: September 30, December 31, 2021 2020 Note payable to Zeo Inc., non interest bearing, payable in 11 quarterly installments of $8,300 with a final payment of $8,700; maturing December 2022; uncollateralized. $ - $ 66,800 Note payable to Cat Financial Services, bearing interest at 6%; payable in monthly installments of $778; maturing December 2022; collateralized by equipment. - 17,480 Note payable to Phyllis Rice, bearing interest at 1%; payable in monthly installments of $2,000; originally maturing March 2015; collateralized by equipment. - 2,146 - 86,426 Less current portion - (52,122 ) Long-term portion $ - $ 34,304

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions
9. Related Party Transactions	9. Related Party Transactions The Company’s previous President and Chairman, John Lawrence, rented equipment to the Company and charged the Company for lodging and meals provided to consultants, customers and other parties by an entity that Mr. Lawrence owned. The amount due to Mr. Lawrence’s estate as of September 30, 2021 and December 31, 2020 was $nil and $171,017. During the nine months ended September 30, 2021, the Company paid off the full amount of $171,017 to John Lawrence’s estate for reimbursement of these expenses. During 2019, Mr. Lawrence advanced funds to the Company that had a balance at December 31, 2020 of $56,215. During the nine month period ended September 30, 2021, the Company paid First Security Bank on behalf of Mr. Lawrence $56,215. The balance of the advances due to Mr. Lawrence at September 30, 2021 is $nil. John C. Gustavsen, Interim CEO of the Company, has an advance due from the Company of $200 at December 31, 2020. During the nine month period ended September 30, 2021, the Company paid $200 to Mr. Gustavsen as reimbursement on these advances. During the nine months ended September 30, 2021, Russ Lawrence, Interim President & Director, incurred expenses of $18,487 and charged the Company for lodging and meals provided to visiting Board of Directors by an entity that Russ Lawrence owns. During the nine month period ended September 30, 2021, the Company paid Russ Lawrence $17,740, leaving a balance due of $747 which is included in accounts payable on the balance sheet.

Stockholders Equity

Stockholders Equity	9 Months Ended
	Sep. 30, 2021
Stockholders' equity:
10. Stockholder's Equity	10. Stockholder’s Equity In February 2021, the Company sold shares of its common stock in two separate transactions: On February 3, 2021, 15,300,000 shares were sold at $0.70 for gross proceeds of $10,710,000; and on February 18, 2021, 10,990,000 shares were sold at at $1.30 for gross proceeds of $14,287,000. A total of $1,654,820 of cash issuance costs were incurred on these sales. During the nine months ended September 30, 2021, the Company accrued $84,375 in directors’ fees payable that will be paid in common stock. During the nine months ended September 30, 2021, the Company issued 112,610 shares of common stock to the board of director’s to satisfy the directors’ fees payable of $110,000 that were outstanding at December 31, 2020. During the nine month period ended September 30, 2021, the Company issued 3,765,477 shares of common stock and received $1,790,703 in cash from the exercise of warrants. For the same period in 2020, the Company’s former president, John Lawrence, exercised warrants for 250,000 shares of common stock in exchange for a payable due to him of $62,500. Warrants Concurrent with the February 3, 2021 sale of common stock, the Company sold warrants to purchase 7,650,000 shares of common stock at an exercise price of $0.85 per share. The warrants are initially exercisable six months following issuance and expire five and one-half years from the issuance date. In connection with the February 2021 sales of common stock, the Company also issued 1,606,500 warrants with an exercise price of $0.85 and 804,000 warrants with an exercise price of $0.46 as commission to the placement agent. Transactions in common stock purchase warrants for the nine month period ended September 30, 2021 and the year ended December 31, 2020 are as follows: Number of Warrants Exercise Prices Balance December 31, 2019 702,041 $ 0.25 - $0.65 Issued 5,742,858 $ 0.46 Exercised (250,000 ) $ 0.25 Balance December 31, 2020 6,194,899 $ 0.46 - $0.65 Issued 10,060,500 $ 0.46- $0.85 Exercised (3,765,477 ) $ 0.46 - $0.65 Balance September 30, 2021 12,489,922 $ 0.46 - $0.85 These warrants expire as follows: Warrants Exercise Price Expiration Date 143,707 $ 0.65 2022 2,285,715 $ 0.46 2026 9,256,500 $ 0.85 2026 804,000 $ 0.46 2026 12,489,922

Income and Other Taxes

Income and Other Taxes	9 Months Ended
	Sep. 30, 2021
Income and Other Taxes
11. Income and Other Taxes	11. Income and Other Taxes Mexican Tax Assessment In 2015, the Mexican tax authority (“SAT”) initiated an audit of the USAMSA’s 2013 income tax return. In October 2016, as a result of its audit, SAT assessed the Company $13.8 million pesos, which was approximately $666,400 in U.S. Dollars (“USD”) as of December 31, 2016. SAT’s assessment was based on the disallowance of specific costs that the Company deducted on the 2013 USAMSA income tax return. The Company engaged accountants and tax attorneys in Mexico to defend its position. The assessment was settled in 2018 with no assessment against the Company. In early 2019, the Company was notified that SAT re-opened its audit of USAMSA’s 2013 income tax return and, in November 2019, SAT assessed the Company $16.3 million pesos, which was approximately $818,000 USD as of September 30, 2021. Management reviewed the 2019 assessment notice from SAT and, similar to the earlier assessment, believes the findings have no merit. The Company engaged a tax attorney in Mexico to defend its position. An appeal was filed by the Company in November 2019 suspending SAT from taking immediate action regarding the assessment. The Company posted a guarantee of the amount in March 2020 as is required under the appeal process. In August 2020, the Company filed a lawsuit against SAT for resolution of the process and, in December 2020, filed closing arguments. Management expects the appeal process to continue through 2021. At September 30, 2021 and December 31, 2020, management assessed the possible outcomes for this tax audit and believes, based on discussions with its tax attorney in Mexico, that the most likely outcome will be that the Company will be successful in its appeal resulting in no tax due. Management determined that no amount should be accrued at September 30, 2021 and December 31, 2020 relating to this potential tax liability. There can be no assurance that the Company’s ultimate liability, if any, will not have a material adverse effect on the Company’s results of operations or financial position. If an issue addressed during the SAT audit is resolved in a manner inconsistent with management expectations, the Company will adjust its current net operating loss carryforward, or accrue penalties, interest, and tax associated with the assessment. Other Taxes In 2016, USAMSA imported coal from the United States to its smelter in Mexico to process Australian concentrates associated with the Hillgrove agreement (Note 12). At that time, the Company applied for and was granted a Maquiladora (IMMEX), in accordance with a Manufacturing and Export Services Industry program offered by the Mexican government to attract and promote foreign investment in Mexico. With the IMMEX, all imported goods to Mexico that are also exported in altered form are exempt from the requirement of paying the 16% tax (IVA). The Company did not pay IVA on any of the imported coal used to process the Australian concentrates. In 2020, the Company was informed by the SAT that it owed the 16% IVA money for all the coal imported for the processing of the Australian concentrates. Additionally, there were penalties and fees that SAT added to the total amount. In late 2020, the Company filed a motion before the Taxpayer’s Defense Agency (PRODECON), but the motion was denied. To avoid exorbitant penalties, the Company elected to pay the assessed amount in early 2021. For the year ended December 31, 2020, the Company recognized an export tax expense of $1,120,730 and accrued a liability for this assessment. The assessment was settled with a payment of $1,120,730 during the three month period ended March 31, 2021.

Hillgrove Advances Payable

Hillgrove Advances Payable	9 Months Ended
	Sep. 30, 2021
Hillgrove Advances Payable
12. Hillgrove Advances Payable	12. Hillgrove Advances Payable On November 7, 2014, the Company entered into an advance and concentrate processing agreement with Hillgrove Mines Pty Ltd of Australia (Hillgrove) in which the Company was advanced funds from Hillgrove to build facilities to process Hillgrove antimony concentrate. The Company has not processed Hillgrove concentrate for more than two years. The agreement requires the Company to pay the advance balance after Hillgrove issues a stop notice. Payments would begin 90 days after the stop notice issue date and be made in six equal and quarterly installments. Hillgrove was acquired by Red River Resources LTD (“Red River”) during 2019. The balance of the advance liability due was $1,134,221 at December 31, 2020. In April 2021, the Company successfully negotiated a settlement with Red River for an agreed upon amount of $1,020,799 which was paid on paid on April 8, 2021. The Company recognized a gain on settlement of the advance in the amount of $113,422 during the three month period ended June 30, 2021.

Business Segments

Business Segments	9 Months Ended
	Sep. 30, 2021
Business Segments
13. Business Segments	13. Business Segments The Company is currently organized and managed by four segments, which represent our operating units: United States antimony operations, Mexican antimony operations, precious metals recovery and United States zeolite operations. The Puerto Blanco mill and the Madero smelter at the Company’s Mexico operation bring antimony up to an intermediate or finished stage, which may be sold directly or shipped to the United States operation for finishing at the Thompson Falls, Montana plant. The Puerto Blanco mill in Mexico is the site of our crushing and flotation plant, and a cyanide leach plant which will recover precious metals after the ore goes through the crushing and flotation cycles. A precious metals recovery plant is operated in conjunction with the antimony processing plant at Thompson Falls, Montana, where a 99% precious metals mix will be produced. The zeolite operation produces zeolite near Preston, Idaho. Almost all of the sales of products from the United States antimony and zeolite operations are to customers in the United States, although the Company does have a sales operation in Canada. Segment disclosure regarding sales to major customers is located in Note 4. Properties, plants and equipment, net: September 30, 2021 December 31, 2020 Antimony United States $ 1,617,981 $ 1,637,738 Mexico 7,215,048 7,635,410 Subtotal Antimony 8,833,029 9,273,148 Precious metals 904,647 933,885 Zeolite 1,438,791 1,018,561 Total $ 11,176,469 $ 11,225,594 At September 30, 2021 and December 31, 2020, the Company had $807,471 and $755,978, respectively, of assets that were not yet placed in service and have not yet been depreciated.\ For the Three Months Ended For the Nine Months Ended Capital expenditures: September 30, 2021 September 30, 2020 September 30, 2021 September 30, 2020 Antimony United States $ 4,060 $ - $ 4,060 $ 32,448 Mexico 4,872 2,923 14,616 33,585 Subtotal Antimony 8,932 2,923 18,676 66,033 Precious Metals 17,607 17,366 54,954 138,211 Zeolite 474,812 - 542,849 16,211 Total $ 501,351 $ 20,289 $ 616,479 $ 220,455 Segment Operations for the three Antimony Antimony Total Precious Bear River months ended September 30, 2021 USAC Mexico Antimony Metals Zeolite Totals Total revenues $ 1,284,969 $ - $ 1,284,969 $ 73,736 $ 693,008 $ 2,051,713 Depreciation and amortization 8,032 145,027 153,059 28,361 41,776 223,196 Income (loss) from operations 528,750 (673,739 ) (144,989 ) 45,375 (12,348 ) (111,962 ) Other income (expense): 13,249 - 13,249 - (519 ) 12,730 NET INCOME (LOSS) $ 541,999 $ (673,739 ) $ (131,740 ) $ 45,375 $ (12,867 ) $ (99,232 ) Segment Operations for the three Antimony Antimony Total Precious Bear River months ended September 30, 2020 USAC Mexico Antimony Metals Zeolite Totals Total revenues $ 477,273 $ - $ 477,273 $ 48,832 $ 481,126 $ 1,007,231 Depreciation and amortization 7,395 146,099 153,494 22,141 42,015 217,650 Income (loss) from operations (208,676 ) (904,337 ) (1,113,013 ) 26,691 96,813 (989,509 ) Other income (expense): (2,883 ) (4 ) (2,887 ) - (844 ) (3,731 ) NET INCOME (LOSS) $ (211,559 ) $ (904,341 ) $ (1,115,900 ) $ 26,691 $ 95,969 $ (993,240 ) Segment Operations for the nine Antimony Antimony Total Precious Bear River months ended September 30, 2021 USAC Mexico Antimony Metals Zeolite Totals Total revenues $ 3,371,015 $ - $ 3,371,015 $ 280,164 $ 1,929,383 $ 5,580,562 Depreciation and amortization 23,816 434,978 458,794 84,191 122,619 665,604 Income (loss) from operations 409,723 (1,487,670 ) (1,077,947 ) 195,973 196,096 (685,878 ) Other income (expense): 476,609 113,422 590,031 - (1,732 ) 588,299 NET INCOME (LOSS) $ 886,332 $ (1,374,248 ) $ (487,916 ) $ 195,973 $ 194,364 $ (97,579 ) Segment Operations for the nine Antimony Antimony Total Precious Bear River months ended September 30, 2020 USAC Mexico Antimony Metals Zeolite Totals Total revenues $ 2,509,183 $ - $ 2,509,183 $ 173,029 $ 1,653,201 $ 4,335,413 Depreciation and amortization 22,184 438,297 460,481 66,422 140,395 667,298 Income (loss) from operations 156,884 (2,182,979 ) (2,026,095 ) 106,607 347,166 (1,572,322 ) Other income (expense): (1,058 ) (4 ) (1,062 ) - (3,021 ) (4,083 ) NET INCOME (LOSS) $ 155,826 $ (2,182,983 ) $ (2,027,157 ) $ 106,607 $ 344,145 $ (1,576,405 )

Note PayableSmall Business Admi

Note PayableSmall Business Administration Loans and Grant	9 Months Ended
	Sep. 30, 2021
Note PayableSmall Business Administration Loans and Grant
14. Note PayableSmall Business Administration Loans and Grant	14. Note Payable-Small Business Administration Loan On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (the “CARES Act”) Act was signed into United States law. On April 20, 2020, the Company received a loan of $443,400 pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the CARES Act, which was enacted March 27, 2020. The loan, which was in the form of a Note dated April 20, 2020 had a maturity date on April 19, 2022 and an interest rate of 1% per annum. The loan was to be forgiven under the provisions of the CARES Act if the Company used the funds for qualifying expenses. Qualifying expenses included payroll costs, costs used to continue group health care benefits, rent, and utilities. During the three month period ended June 30, 2021, the Company received notification that the loan had been forgiven. The amount of the loan, $443,400, was recognized as gain on forgiveness of the CARES Act loan.

Income (Loss) Per Common Share

Income (Loss) Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2021
Net loss per share of common stock:
Antidilutive securities excluded from computation of earnings per share	September 30, 2021 September 30, 2020 Warrants 12,489,922 6,194,899 Convertible preferred stock 1,751,005 1,751,005 Total possible dilution 14,240,927 7,945,904

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2021
Revenue Recognition
Disaggregation of revenue	Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Antimony $ 1,284,969 $ 477,273 $ 3,371,015 $ 2,509,183 Zeolite 693,008 481,126 1,929,383 1,653,201 Precious metals 73,736 48,832 280,164 173,029 $ 2,051,713 $ 1,007,231 $ 5,580,562 $ 4,335,413
Revenue by geographic area	Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 United States $ 1,805,456 $ 891,090 $ 4,954,412 $ 3,893,374 Canada 246,257 116,141 626,150 442,039 $ 2,051,713 $ 1,007,231 $ 5,580,562 $ 4,335,413
Schedule of account receivable from largest customers	Largest Accounts Receivable September 30, 2021 December 31, 2020 Company B $ 222,100 $ - Company F 110,864 - Company G 54,400 68,055 Company H - 21,619 Company I - 16,600 Company J - 12,255 $ 387,364 $ 118,529 % of Total Receivables 53.60 % 49.67 %
Sales of products to significant customers	For the Three Months Ended For the Nine Months Ended Sales to September 30, September 30, September 30, September 30, Largest Customers 2021 2020 2021 2020 Company A 288,640 114,075 778,211 404,447 Company B 581,609 105,865 1,284,206 - Company C - - 518,226 523,660 Company D 225,800 - 225,800 - Company E - 131,360 - 345,899 $ 1,096,049 $ 351,300 $ 2,806,443 $ 1,274,006 % of Total Revenues 53.42 % 34.88 % 50.29 % 29.39 %

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2021
Inventories
Inventories	September 30, 2021 December 31, 2020 Antimony Metal $ 116,325 $ 268,100 Antimony Oxide 214,659 67,377 Antimony Ore 211,788 95,880 Total antimony 542,772 431,357 Zeolite 191,184 218,856 $ 733,956 $ 650,213

Notes Payable to Bank (Tables)

Notes Payable to Bank (Tables)	9 Months Ended
	Sep. 30, 2021
Notes Payable to Bank
Notes payable to bank	2021 2020 Promissory note payable to First Security Bank of Missoula, bearing interest at 3.150%, payable on demand, collateralized by a lien on Certificate of Deposit $ - $ 99,999 Promissory note payable to First Security Bank of Missoula, bearing interest at 3.150%, payable on demand, collateralized by a lien on Certificate of Deposit - 1 Total notes payable to the bank $ - $ 100,000

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2021
Debt
Long-term debt	September 30, December 31, 2021 2020 Note payable to Zeo Inc., non interest bearing, payable in 11 quarterly installments of $8,300 with a final payment of $8,700; maturing December 2022; uncollateralized. $ - $ 66,800 Note payable to Cat Financial Services, bearing interest at 6%; payable in monthly installments of $778; maturing December 2022; collateralized by equipment. - 17,480 Note payable to Phyllis Rice, bearing interest at 1%; payable in monthly installments of $2,000; originally maturing March 2015; collateralized by equipment. - 2,146 - 86,426 Less current portion - (52,122 ) Long-term portion $ - $ 34,304

Stockholders Equity (Tables)

Stockholders Equity (Tables)	9 Months Ended
	Sep. 30, 2021
Stockholders' equity:
Common stock warrant activity	Number of Warrants Exercise Prices Balance December 31, 2019 702,041 $ 0.25 - $0.65 Issued 5,742,858 $ 0.46 Exercised (250,000 ) $ 0.25 Balance December 31, 2020 6,194,899 $ 0.46 - $0.65 Issued 10,060,500 $ 0.46- $0.85 Exercised (3,765,477 ) $ 0.46 - $0.65 Balance September 30, 2021 12,489,922 $ 0.46 - $0.85
Warrants outstanding	Warrants Exercise Price Expiration Date 143,707 $ 0.65 2022 2,285,715 $ 0.46 2026 9,256,500 $ 0.85 2026 804,000 $ 0.46 2026 12,489,922

Business Segments (Tables)

Business Segments (Tables)	9 Months Ended
	Sep. 30, 2021
Business Segments
Segment information	Properties, plants and equipment, net: September 30, 2021 December 31, 2020 Antimony United States $ 1,617,981 $ 1,637,738 Mexico 7,215,048 7,635,410 Subtotal Antimony 8,833,029 9,273,148 Precious metals 904,647 933,885 Zeolite 1,438,791 1,018,561 Total $ 11,176,469 $ 11,225,594
Summary of capital expenditure	For the Three Months Ended For the Nine Months Ended Capital expenditures: September 30, 2021 September 30, 2020 September 30, 2021 September 30, 2020 Antimony United States $ 4,060 $ - $ 4,060 $ 32,448 Mexico 4,872 2,923 14,616 33,585 Subtotal Antimony 8,932 2,923 18,676 66,033 Precious Metals 17,607 17,366 54,954 138,211 Zeolite 474,812 - 542,849 16,211 Total $ 501,351 $ 20,289 $ 616,479 $ 220,455
Summary of segement operation	Segment Operations for the three Antimony Antimony Total Precious Bear River months ended September 30, 2021 USAC Mexico Antimony Metals Zeolite Totals Total revenues $ 1,284,969 $ - $ 1,284,969 $ 73,736 $ 693,008 $ 2,051,713 Depreciation and amortization 8,032 145,027 153,059 28,361 41,776 223,196 Income (loss) from operations 528,750 (673,739 ) (144,989 ) 45,375 (12,348 ) (111,962 ) Other income (expense): 13,249 - 13,249 - (519 ) 12,730 NET INCOME (LOSS) $ 541,999 $ (673,739 ) $ (131,740 ) $ 45,375 $ (12,867 ) $ (99,232 ) Segment Operations for the three Antimony Antimony Total Precious Bear River months ended September 30, 2020 USAC Mexico Antimony Metals Zeolite Totals Total revenues $ 477,273 $ - $ 477,273 $ 48,832 $ 481,126 $ 1,007,231 Depreciation and amortization 7,395 146,099 153,494 22,141 42,015 217,650 Income (loss) from operations (208,676 ) (904,337 ) (1,113,013 ) 26,691 96,813 (989,509 ) Other income (expense): (2,883 ) (4 ) (2,887 ) - (844 ) (3,731 ) NET INCOME (LOSS) $ (211,559 ) $ (904,341 ) $ (1,115,900 ) $ 26,691 $ 95,969 $ (993,240 ) Segment Operations for the nine Antimony Antimony Total Precious Bear River months ended September 30, 2021 USAC Mexico Antimony Metals Zeolite Totals Total revenues $ 3,371,015 $ - $ 3,371,015 $ 280,164 $ 1,929,383 $ 5,580,562 Depreciation and amortization 23,816 434,978 458,794 84,191 122,619 665,604 Income (loss) from operations 409,723 (1,487,670 ) (1,077,947 ) 195,973 196,096 (685,878 ) Other income (expense): 476,609 113,422 590,031 - (1,732 ) 588,299 NET INCOME (LOSS) $ 886,332 $ (1,374,248 ) $ (487,916 ) $ 195,973 $ 194,364 $ (97,579 ) Segment Operations for the nine Antimony Antimony Total Precious Bear River months ended September 30, 2020 USAC Mexico Antimony Metals Zeolite Totals Total revenues $ 2,509,183 $ - $ 2,509,183 $ 173,029 $ 1,653,201 $ 4,335,413 Depreciation and amortization 22,184 438,297 460,481 66,422 140,395 667,298 Income (loss) from operations 156,884 (2,182,979 ) (2,026,095 ) 106,607 347,166 (1,572,322 ) Other income (expense): (1,058 ) (4 ) (1,062 ) - (3,021 ) (4,083 ) NET INCOME (LOSS) $ 155,826 $ (2,182,983 ) $ (2,027,157 ) $ 106,607 $ 344,145 $ (1,576,405 )

Basis of Presentation (Details

Basis of Presentation (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Basis of Presentation
Working capital	$ 21,200,000
Accumulated deficit	(32,748,373)	$ (32,650,794)
Proceeds from Sale of Common Stock	23,300,000
Proceeds from exercise of stock purchase warrants	$ 1,800,000

Income (Loss) Per Common Shar_2

Income (Loss) Per Common Share (Details) - shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Total possible dilution	14,240,927	7,945,904
Warrants
Total possible dilution	12,489,922	6,194,899
Cumulative Preferred Stock
Total possible dilution	1,751,005	1,751,005

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 23, 2020
Revenues	$ 2,051,713	$ 1,007,231	$ 5,580,562	$ 4,335,413	$ 4,335,413
Zeolite
Revenues	693,008	481,126	1,929,383	1,653,201	1,653,201
Precious Metals
Revenues	73,736	48,832	280,164	$ 173,029	173,029
Antimony
Revenues	$ 1,284,969	$ 477,273	$ 3,371,015		$ 2,509,183

Revenue Recognition (Details 1)

Revenue Recognition (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 23, 2020
Revenues	$ 2,051,713	$ 1,007,231	$ 5,580,562	$ 4,335,413	$ 4,335,413
United States
Revenues	1,805,456	891,090	4,954,412	3,893,374
Canada
Revenues	$ 246,257	$ 116,141	$ 626,150	$ 442,039

Revenue Recognition (Details 2)

Revenue Recognition (Details 2) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Sales to largest customers	$ 1,096,049	$ 351,300	$ 2,806,443	$ 1,274,006
Total percentage of revenue	53.42%	34.88%	50.29%	29.39%
Company A
Sales to largest customers	$ 288,640	$ 114,075	$ 778,211	$ 404,447
Company B
Sales to largest customers	581,609	105,865	1,284,206	0
Company E
Sales to largest customers	0	131,360	0	345,899
Company C
Sales to largest customers	0	0	518,226	523,660
Company D
Sales to largest customers	$ 225,800	$ 0	$ 225,800	$ 0

Revenue Recognition (Details 3)

Revenue Recognition (Details 3) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Account receivables	$ 722,727
Percentage of Total Receivables	53.60%	49.67%
Company B
Percentage of Total Receivables	38.94%	28.52%
Accounts receivable	$ 222,100	$ 0
Company H
Accounts receivable	0	21,619
Company G
Accounts receivable	54,400	68,055
Company I
Accounts receivable	0	16,600
Company J
Accounts receivable	0	12,255
Company F
Accounts receivable	$ 110,864	$ 0

Revenue Recognition (Details Na

Revenue Recognition (Details Narrative)	9 Months Ended
	Sep. 30, 2021USD ($)
Revenue Recognition
Accounts receivable	$ 722,727
Description of sales orders backlogs	the Company had a sales order backlog of 1,192 tons of zeolite and 44,092 pounds of antimony

Inventories (Details)

Inventories (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Inventories	$ 733,956	$ 650,213
Zeolite
Inventories	191,184	218,856
Antimony Ore
Inventories	211,788	95,880
Antimony
Inventories	542,772	431,357
Antimony Metal
Inventories	116,325	268,100
Antimony Oxide
Inventories	$ 214,659	$ 67,377

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Commitments and Contingencies
Royalty expense	$ 64,212	$ 52,569	$ 195,779	$ 178,187
Accrued royalties payable	$ 376,704		$ 376,704		$ 434,981

Notes Payable to Bank (Details)

Notes Payable to Bank (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Note payable to bank	$ 0	$ 100,000
Promissory Note Payable 1
Note payable to bank	0	99,999
Promissory Note Payable 2
Note payable to bank	$ 0	$ 1

Notes Payable to Bank (Details

Notes Payable to Bank (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Notes Payable to Bank
Proceeds from redemption of certificates of deposit	$ 210,184	$ 0
Certificate of Deposit	$ 44,028		$ 254,212

Debt (Details)

Debt (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Total debt	$ 0	$ 86,426
Less current portion	0	(52,122)
Long-term portion	0	34,304
Zeo Inc.
Total debt	0	66,800
Cat Financial Services
Total debt	0	17,480
Phyllis Rice
Total debt	$ 0	$ 2,146

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020
Reimbursement of expenses.	$ 171,017
Amount due to relates party	171,017			$ 227,432
Repayment of related party debt	56,416	$ 64,650
President and Chairman [Member]
Repayment of related party debt	56,215		$ 56,215
Advances from related party	0			56,215
Chief Executive Officer [Member]
Repayment of related party debt	200		$ 200
Advances from related party	200			$ 200
Mr. Lawrence
Amount due to relates party	17,740
Expenses	18,487
Payables to related party	$ 747

Stockholders Equity (Details)

Stockholders Equity (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Number of warrants, beginning	6,194,899	702,041
Issued	10,060,500	5,742,858
Exercised	3,765,477	250,000
Number of warrants, ending	12,489,922	6,194,899
Issued		$ 0.46
Exercised		0.25
Minimum
Issued	$ 0.46
Exercised	0.46
Warrants exercise price, beginning	0.46	0.25
Warrants exercise price, ending	0.46	0.46
Maximum
Issued	0.85
Exercised	0.65
Warrants exercise price, beginning	0.85	0.65
Warrants exercise price, ending	$ 0.85	$ 0.85

Stockholders Equity (Details 1)

Stockholders Equity (Details 1)	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Warrants
Shares	12,489,922
Warrant 4
Shares	804,000
Exercise Price | $ / shares	$ 0.46
Expiration date	2026
Warrant 3
Shares	9,256,500
Exercise Price | $ / shares	$ 0.85
Expiration date	2026
Warrant 1
Shares	143,707
Exercise Price | $ / shares	$ 0.65
Expiration date	2022
Warrant 2
Shares	2,285,715
Exercise Price | $ / shares	$ 0.46
Expiration date	2026

Stockholders Equity (Details Na

Stockholders Equity (Details Narrative) - USD ($)	Feb. 03, 2021	Feb. 18, 2021	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021	Dec. 31, 2020
Accrued fees payable					$ 112,610	$ 110,000
Common stock shares issued during the period			3,765,477	250,000
Proceeds from issuance of cost			$ 1,790,703	$ 62,500
Director fees			84,375
Gross proceeds from shares sold			$ 23,300,000
Warrant 1
Warrants sold to purchase shares of common stock	7,650,000		1,606,500
Warrants, exercise price	$ 0.85				$ 0.85
Warrant 2
Warrants sold to purchase shares of common stock			804,000
Warrants, exercise price					0.46
February 2021 [Member]
Common stock shares sold	15,300,000	10,990,000
Total cash issuance cost			$ 1,654,820
Shares sold price per share	$ 0.70	$ 1.30
Gross proceeds from shares sold	$ 10,710,000	$ 14,287,000
Warrants sold to purchase shares of common stock			7,650,000
Warrants, exercise price					$ 0.85

Income and Other Taxes (Details

Income and Other Taxes (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Export tax expense			$ 1,120,730
Payment settlement of assessed amount	$ 1,120,730
2015 [Member]
Mexico tax assessment, description		In October 2016, as a result of its audit, SAT assessed the Company $13.8 million pesos, which was approximately $666,400 in U.S. Dollars (“USD”) as of December 31, 2016
2019 [Member]
Mexico tax assessment, description		SAT assessed the Company $16.3 million pesos, which was approximately $818,000 USD as of September 30, 2021

Hillgrove Advances Payable (Det

Hillgrove Advances Payable (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended
	Apr. 30, 2021	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Hillgrove advances payable, current			$ 0		$ 378,074
Payments on Hillgrove advances payable			1,020,799	$ 0
Concentrate Processing Agreement [Member] | Hillgrove Mines Ltd [Member]
Hillgrove advances payable, current					$ 1,134,221
Gains on settlement		$ 113,422
Payments on Hillgrove advances payable	$ (1,020,799)		$ (1,020,799)

Business Segments (Details)

Business Segments (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Properties, plants and equipment, net	$ 11,176,469	$ 11,225,594
United States Antimony
Properties, plants and equipment, net	1,617,981	1,637,738
Mexico Antimony
Properties, plants and equipment, net	7,215,048	7,635,410
Subtotal Antimony
Properties, plants and equipment, net	8,833,029	9,273,148
Precious Metals
Properties, plants and equipment, net	904,647	933,885
Zeolite
Properties, plants and equipment, net	$ 1,438,791	$ 1,018,561

Business Segments (Details 1)

Business Segments (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Capital expenditures	$ 501,351	$ 20,289	$ 616,479	$ 220,455
United States Antimony
Capital expenditures	4,060	0	4,060	32,448
Mexico Antimony
Capital expenditures	4,872	2,923	14,616	33,585
Subtotal Antimony
Capital expenditures	8,932	2,923	18,676	66,033
Precious Metals
Capital expenditures	17,607	17,366	54,954	138,211
Zeolite
Capital expenditures	$ 474,812	$ 0	$ 542,849	$ 16,211

Business Segments (Details 2)

Business Segments (Details 2) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 23, 2020
Revenues	$ 2,051,713	$ 1,007,231	$ 5,580,562	$ 4,335,413	$ 4,335,413
Depreciation and amortization	223,196	217,650	665,604	667,298
Income (loss) from operations	(111,962)	(989,509)	(685,878)	(1,572,322)
Total other income (expense)	12,730	(3,731)	588,299	(4,083)
Net loss	(99,232)	(993,240)	(97,579)	(1,576,405)
United States Antimony
Revenues	1,284,969	477,273	3,371,015	2,509,183
Depreciation and amortization	8,032	7,395	23,816	22,184
Income (loss) from operations	528,750	(208,676)	409,723	156,884
Total other income (expense)	13,249	(2,883)	476,609	(1,058)
Net loss	541,999	(211,559)	886,332	155,826
Mexico Antimony
Revenues	0	0	0	0
Depreciation and amortization	145,027	146,099	434,978	438,297
Income (loss) from operations	(673,739)	(904,337)	(1,487,670)	(2,182,979)
Total other income (expense)	0	(4)	113,422	(4)
Net loss	(673,739)	(904,341)	(1,374,248)	(2,182,983)
Subtotal Antimony
Revenues	1,284,969	477,273	3,371,015	2,509,183
Depreciation and amortization	153,059	153,494	458,794	460,481
Income (loss) from operations	(144,989)	(1,113,013)	(1,077,947)	(2,026,095)
Total other income (expense)	13,249	(2,887)	590,031	(1,062)
Net loss	(131,740)	(1,115,900)	(487,916)	(2,027,157)
Precious Metals
Revenues	73,736	48,832	280,164	173,029	173,029
Depreciation and amortization	28,361	22,141	84,191	66,422
Income (loss) from operations	45,375	26,691	195,973	106,607
Total other income (expense)	0	0	0	0
Net loss	45,375	26,691	195,973	106,607
Zeolite
Revenues	693,008	481,126	1,929,383	1,653,201	$ 1,653,201
Depreciation and amortization	41,776	42,015	122,619	140,395
Income (loss) from operations	(12,348)	(96,813)	196,096	347,166
Total other income (expense)	(519)	(844)	(1,732)	(3,021)
Net loss	$ 12,867	$ 95,969	$ 194,364	$ 344,145

Business Segments (Details Narr

Business Segments (Details Narrative) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Business Segments
Remaining amount of assets	$ 807,471	$ 755,978

Note Payable-Small Business Adm

Note Payable-Small Business Administration Loan (Details Narrative) - PayCheck Protection Program [Member]	1 Months Ended
	Apr. 20, 2020USD ($)
Loan received amount	$ 443,400
Interest rate, loan	1.00%
Maturity date	Apr. 19, 2022
Gain on forgivness loan amount	$ 443,400